CJC-1295 with DAC and Pitavastatin Interaction
CJC-1295 with DAC and Pitavastatin have a synergistic interaction with 60% confidence. Pitavastatin helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. These compounds primarily affect different organ systems.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profilePitavastatin
HMG-CoA Reductase Inhibitor | Low-Interaction Statin
Pitavastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for cholesterol biosynthesis in the liver. By blocking this enzyme, pitavastatin reduces intracellular cholesterol concentration in hepatocytes, triggering compensatory upregulation of LDL receptor expression on the hepatocyte surface.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take CJC-1295 with DAC with Pitavastatin?
Yes, CJC-1295 with DAC and Pitavastatin can generally be taken together. Pitavastatin helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.
Is CJC-1295 with DAC and Pitavastatin safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between CJC-1295 with DAC and Pitavastatin?
Pitavastatin helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 with DAC and Pitavastatin?
CJC-1295 with DAC has a half-life of 6-8 days and Pitavastatin has a half-life of ~12 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.